Mobile

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Mise à jour : Il y a 4 ans
Référence : NCT00109590

Femme Homme

  • | Pays :
  • Thailand
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The purpose of this study is to determine which of 3 different anti-HIV drug regimens given to HIV infected pregnant women during and after their pregnancies is most effective in reducing the incidence of nevirapine (NVP) resistance mutations. Blood levels of NVP and lopinavir/ritonavir (LPV/r) will also be studied. Study hypothesis: NVP resistance following single-dose NVP can be prevented with the concomitant administration of additional antiretroviral therapy (ART).

Critère d'inclusion

  • HIV Infections

Liens